132 related articles for article (PubMed ID: 11779433)
21. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.
Salinas-Sánchez AS; Atienzar-Tobarra M; Lorenzo-Romero JG; Sánchez-Sánchez F; Giménez-Bachs JM; Donate-Moreno MJ; Pastor-Navarro H; Hernández-Millán I; Segura-Martín M; Escribano-Martínez J
Urol Int; 2007; 79(4):321-7. PubMed ID: 18025850
[TBL] [Abstract][Full Text] [Related]
24. Detection of p53 gene mutations in human leukemia by PCR-SSCP analysis and direct nucleotide sequencing.
Wang R; Yu Z; Gu J; Li D; Wang M; Cao Y
Chin Med J (Engl); 1998 Apr; 111(4):339-42. PubMed ID: 10374399
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
26. p53 gene mutations are rare in human papillomavirus-associated colon cancer.
Buyru N; Budak M; Yazici H; Dalay N
Oncol Rep; 2003; 10(6):2089-92. PubMed ID: 14534749
[TBL] [Abstract][Full Text] [Related]
27. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
[TBL] [Abstract][Full Text] [Related]
28. No correlation of c-myc overexpression and p53 mutations in liposarcomas.
Schneider-Stock R; Walter H; Rys J; Radig K; Hoang-Vu C; Roessner A
Virchows Arch; 1998 Oct; 433(4):315-21. PubMed ID: 9808433
[TBL] [Abstract][Full Text] [Related]
29. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
Kudawara I; Matsumine A; Ohzono K
J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
[TBL] [Abstract][Full Text] [Related]
30. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.
Meyers FJ; Gumerlock PH; Chi SG; Borchers H; Deitch AD; deVere White RW
Cancer; 1998 Dec; 83(12):2534-9. PubMed ID: 9874460
[TBL] [Abstract][Full Text] [Related]
31. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
[TBL] [Abstract][Full Text] [Related]
32. [The status of p53 gene in the primary retinoblastoma].
Huang Q
Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):248-51. PubMed ID: 11835813
[TBL] [Abstract][Full Text] [Related]
33. [Detection of point mutation in p53 gene by capillary electrophoresis-PCR-SSCP analysis].
Liu J; Jing H; Ru Q; Deng Y; Luo G; Huang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):476-9. PubMed ID: 12910694
[TBL] [Abstract][Full Text] [Related]
34. [The research on p53 gene mutation in lung cancer tissue of silicotic patients by PCR-SSCR].
Zhou P; Liu B; Miao Q; Wang H
Wei Sheng Yan Jiu; 1997 Sep; 26(5):293-5, 298. PubMed ID: 10325639
[TBL] [Abstract][Full Text] [Related]
35. [Detection of p53 gene mutation in paraffin-embedded asbestos-related lung cancer tissue].
Fu D; Liu B; Wang H
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Jul; 31(4):206-8. PubMed ID: 9812577
[TBL] [Abstract][Full Text] [Related]
36. [PCR-SSCP and sequencing analysis on mutations of anti-oncogene p53 in asbestos-related lung cancer].
Fu D; Liu B; Miao Q; Wang H
Wei Sheng Yan Jiu; 1997 Sep; 26(5):289-92. PubMed ID: 10325638
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
38. Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis.
Kutach LS; Bolshakov S; Ananthaswamy HN
Electrophoresis; 1999 Jun; 20(6):1204-10. PubMed ID: 10380760
[TBL] [Abstract][Full Text] [Related]
39. [The relationship between p53 mutation and esophageal cancer biological behavior].
He Y; Li M; Shang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):1-4. PubMed ID: 9456364
[TBL] [Abstract][Full Text] [Related]
40. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
